blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1157122

EP1157122 - ANTI-NEOPLASTIC COMPOSITIONS AND USES THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  09.04.2004
Database last updated on 16.11.2024
Most recent event   Tooltip09.04.2004Application deemed to be withdrawnpublished on 26.05.2004  [2004/22]
Applicant(s)For all designated states
CELL GENESYS, INC.
342 Lakeside Drive
Foster City, CA 94404 / US
For all designated states
GPC Biotech Inc.
One Kendall Square, Building 600
Cambridge, MA 02139 / US
[2001/48]
Inventor(s)01 / PATEL, Salil
21230 Homestead Road 10
Cupertino, CA 95014 / US
02 / MCARTHUR, James
2056 White Oaks Way
San Carlos, CA 94070 / US
03 / GYURIS, Jeno
171 Swanton Street
Winchester, MA 01890 / US
04 / MENDEZ, Michael, J. Syrrx, Inc.
10450 Science Center Dr., Suite 100
San Diego, CA 92121 / US
05 / FINER, Mitchell
21 Oakhaven
Woodside, CA 94062 / US
 [2002/10]
Former [2001/48]01 / PATEL, Salil
21230 Homestead Road 10
Cupertino, CA 95014 / US
02 / MCARTHUR, James
2056 White Oaks Way
San Carlos, CA 94070 / US
03 / GYURIS, Jeno
171 Swanton Street
Winchester, MA 01890 / US
04 / MENDEZ, Michael, J.
471 El Granada Boulevard
El Granada, CA 94018 / US
05 / FINER, Mitchell
21 Oakhaven
Woodside, CA 94062 / US
Representative(s)Hallybone, Huw George, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2001/48]Hallybone, Huw George, et al
CARPMAELS AND RANSFORD 43 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date00912114.601.03.2000
[2001/48]
WO2000US05350
Priority number, dateUS19990122974P01.03.1999         Original published format: US 122974 P
US19990128271P08.04.1999         Original published format: US 128271 P
US19990128515P09.04.1999         Original published format: US 128515 P
[2001/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0052184
Date:08.09.2000
Language:EN
[2000/36]
Type: A1 Application with search report 
No.:EP1157122
Date:28.11.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 08.09.2000 takes the place of the publication of the European patent application.
[2001/48]
Search report(s)International search report - published on:EP08.09.2000
ClassificationIPC:C12N15/86, C12N15/62, C07K14/075, C07K14/47, A61K31/70, A61K38/17, A61P35/00
[2001/48]
CPC:
C12N15/86 (EP,US); A61P35/00 (EP); C07K14/4738 (EP,US);
C12N15/62 (EP,US); A61K38/00 (EP,US); A61K48/00 (EP,US);
C07K2319/00 (EP,US); C07K2319/02 (EP,US); C07K2319/10 (EP,US);
C07K2319/21 (EP,US); C07K2319/23 (EP,US); C07K2319/42 (EP,US);
C07K2319/43 (EP,US); C07K2319/75 (EP,US); C12N2710/10322 (EP,US);
C12N2710/10343 (EP,US); C12N2740/16043 (EP,US); C12N2830/002 (EP,US);
C12N2830/60 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/48]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:ANTINEOPLASTISCHE ZUSAMMENSETZUNGEN UND DEREN VERWENDUNGEN[2001/48]
English:ANTI-NEOPLASTIC COMPOSITIONS AND USES THEREOF[2001/48]
French:COMPOSITIONS ANTI-NEOPLASIQUES ET LEURS UTILISATIONS[2001/48]
Entry into regional phase17.09.2001National basic fee paid 
17.09.2001Designation fee(s) paid 
17.09.2001Examination fee paid 
Examination procedure02.10.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
17.09.2001Examination requested  [2001/48]
18.06.2003Despatch of a communication from the examining division (Time limit: M04)
29.10.2003Application deemed to be withdrawn, date of legal effect  [2004/22]
03.12.2003Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2004/22]
Fees paidRenewal fee
17.09.2001Renewal fee patent year 03
24.03.2003Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[XA]WO9727297  (MITOTIX INC [US]) [X] 1-8,26 * abstract * * page 10, line 27 - line 32 * * page 20, line 32 - page 24, line 22 * * page 28, line 12 - line 18 * * page 29, line 23 - line 30 * * page 33, line 31 - page 36, line 17 * [A] 9-25,27-31;
 [A]WO9801563  (BRANTON PHILIP E [CA], et al) [A] 1-31 * abstract * * claims 1-80 *;
 [X]WO9903508  (UNIV MICHIGAN [US]) [X] 1,3-8,26 * claims 1-16 *;
 [PX]  - MCATHUR J.G. ET AL., "Cancer gene therapy with novel chimeric p27/p16 tumor suppressor genes", PROC. AMER. ASSN. CANCER RES., (199903), vol. 40, page 630, XP002144030 [PX] 1-8,26 * the whole document *
 [A]  - KWON T.K. ET AL., "The cdk2 binding domain of p27Kip correlates with the inhibition of the kinase activity of cdk2/cyclin complexes", BIOCHEM. BIOPHYS. RES. COM., (1996), vol. 220, pages 703 - 709, XP002144031 [A] 10,18,23 * the whole document *

DOI:   http://dx.doi.org/10.1006/bbrc.1996.0468
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.